Butorphanol-Azaperone-Medetomidine Is as Safe and Effective as Nalbuphine-Azaperone-Medetomidine for Immobilization of Juvenile American Black Bears (Ursus americanus)
© Wildlife Disease Association 2024..
Immobilization kits including butorphanol-azaperone-medetomidine (BAM) and nalbuphine-azaperone-medetomidine can provide effective, safe, and easy-to-use protocols in bears. Nalbuphine-azaperone-medetomidine is not commercially available but may be useful for wildlife agencies because it does not contain controlled substances. This study directly compared BAM to nalbuphine-azaperone-medetomidine immobilization in 10 juvenile healthy black bears (10 mo old; four females, six males) undergoing prerelease examinations after rehabilitation. Bears were immobilized via remote delivery of 1 mL of BAM (n=5) or nalbuphine-azaperone-medetomidine (n=5) intramuscularly in the shoulder during December (randomized, blinded trial). Bears were intubated, monitored with an electrocardiogram, pulse oximeter, capnograph, noninvasive blood pressure cuff, and rectal thermometer, and underwent physical examination, sample collection, morphometrics, and ear-tag placement. Induction, physiologic, and recovery parameters were recorded, including arterial blood gas analysis. The anesthetic agents were antagonized with atipamezole and naltrexone. There were no differences between protocols in induction or recovery times. There were no differences between protocols in heart rate, respiratory rate, temperature, oxygen saturation, end-tidal CO2, mean arterial pressure, or blood gas analysis or any differences between male and female bears in any parameters. Bears were hypertensive and normoxemic with low oxygen saturation via pulse oximeter, but all recovered smoothly and were released within 2 h of recovery. This study supports that nalbuphine-azaperone-medetomidine is clini-cally as safe and effective as BAM in American black bears.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Journal of wildlife diseases - 60(2024), 1 vom: 01. Jan., Seite 188-192 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sheldon, Julie D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
19BV78AK7W |
|---|
| Anmerkungen: |
Date Completed 05.01.2024 Date Revised 23.04.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.7589/JWD-D-23-00043 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36401315X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36401315X | ||
| 003 | DE-627 | ||
| 005 | 20240423232015.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7589/JWD-D-23-00043 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1384.xml |
| 035 | |a (DE-627)NLM36401315X | ||
| 035 | |a (NLM)37909402 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sheldon, Julie D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Butorphanol-Azaperone-Medetomidine Is as Safe and Effective as Nalbuphine-Azaperone-Medetomidine for Immobilization of Juvenile American Black Bears (Ursus americanus) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2024 | ||
| 500 | |a Date Revised 23.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Wildlife Disease Association 2024. | ||
| 520 | |a Immobilization kits including butorphanol-azaperone-medetomidine (BAM) and nalbuphine-azaperone-medetomidine can provide effective, safe, and easy-to-use protocols in bears. Nalbuphine-azaperone-medetomidine is not commercially available but may be useful for wildlife agencies because it does not contain controlled substances. This study directly compared BAM to nalbuphine-azaperone-medetomidine immobilization in 10 juvenile healthy black bears (10 mo old; four females, six males) undergoing prerelease examinations after rehabilitation. Bears were immobilized via remote delivery of 1 mL of BAM (n=5) or nalbuphine-azaperone-medetomidine (n=5) intramuscularly in the shoulder during December (randomized, blinded trial). Bears were intubated, monitored with an electrocardiogram, pulse oximeter, capnograph, noninvasive blood pressure cuff, and rectal thermometer, and underwent physical examination, sample collection, morphometrics, and ear-tag placement. Induction, physiologic, and recovery parameters were recorded, including arterial blood gas analysis. The anesthetic agents were antagonized with atipamezole and naltrexone. There were no differences between protocols in induction or recovery times. There were no differences between protocols in heart rate, respiratory rate, temperature, oxygen saturation, end-tidal CO2, mean arterial pressure, or blood gas analysis or any differences between male and female bears in any parameters. Bears were hypertensive and normoxemic with low oxygen saturation via pulse oximeter, but all recovered smoothly and were released within 2 h of recovery. This study supports that nalbuphine-azaperone-medetomidine is clini-cally as safe and effective as BAM in American black bears | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a American black bear | |
| 650 | 4 | |a azaperone | |
| 650 | 4 | |a butorphanol | |
| 650 | 4 | |a medetomidine | |
| 650 | 4 | |a nalbuphine, Ursus americanus | |
| 650 | 7 | |a Medetomidine |2 NLM | |
| 650 | 7 | |a MR15E85MQM |2 NLM | |
| 650 | 7 | |a Azaperone |2 NLM | |
| 650 | 7 | |a 19BV78AK7W |2 NLM | |
| 650 | 7 | |a Butorphanol |2 NLM | |
| 650 | 7 | |a QV897JC36D |2 NLM | |
| 650 | 7 | |a Nalbuphine |2 NLM | |
| 650 | 7 | |a L2T84IQI2K |2 NLM | |
| 650 | 7 | |a Hypnotics and Sedatives |2 NLM | |
| 650 | 7 | |a Oxygen |2 NLM | |
| 650 | 7 | |a S88TT14065 |2 NLM | |
| 700 | 1 | |a Zhu, Xiaojuan |e verfasserin |4 aut | |
| 700 | 1 | |a Williamson, Ryan |e verfasserin |4 aut | |
| 700 | 1 | |a Blair, Coy |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of wildlife diseases |d 1970 |g 60(2024), 1 vom: 01. Jan., Seite 188-192 |w (DE-627)NLM000006912 |x 1943-3700 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:188-192 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7589/JWD-D-23-00043 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2024 |e 1 |b 01 |c 01 |h 188-192 | ||